Intellia Therapeutics, Inc. - Common Stock (NTLA)

CUSIP: 45826J105

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common Stock
Shares outstanding
116,932,531
Total 13F shares
14,253,796
Share change
+92,611
Total reported value
$242,822,100
Price per share
$17.02
Number of holders
64
Value change
+$573,360
Number of buys
35
Number of sells
25

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NTLA - Intellia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
4.5%
5,254,407
$112,182,000 30 Jun 2016
13F
ORBIMED ADVISORS LLC
13F
Company
2.3%
2,662,180
$56,838,000 30 Jun 2016
13F
BAKER BROS. ADVISORS LP
13F
Company
0.91%
1,062,120
$22,676,000 30 Jun 2016
13F
Temasek Holdings (Private) Ltd
13F
Company
0.68%
790,527
$16,878,000 30 Jun 2016
13F
Foresite Capital Management III, LLC
13F
Company
0.65%
763,688
$16,305,000 30 Jun 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0.53%
615,749
$13,146,000 30 Jun 2016
13F
VANGUARD GROUP INC
13F
Company
0.36%
416,564
$8,894,000 30 Jun 2016
13F
EcoR1 Capital, LLC
13F
Company
0.27%
310,695
$6,633,000 30 Jun 2016
13F
MORGAN STANLEY
13F
Company
0.26%
301,358
$6,434,000 30 Jun 2016
13F
FRANKLIN RESOURCES INC
13F
Company
0.26%
300,000
$6,405,000 30 Jun 2016
13F
Artal Group S.A.
13F
Company
0.19%
225,000
$4,804,000 30 Jun 2016
13F
BlackRock Fund Advisors
13F
Company
0.14%
163,768
$3,496,000 30 Jun 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.12%
144,002
$3,074,000 30 Jun 2016
13F
Tekla Capital Management LLC
13F
Company
0.07%
86,842
$1,854,000 30 Jun 2016
13F
Invesco Ltd.
13F
Company
0.07%
82,994
$1,771,000 30 Jun 2016
13F
Neuberger Berman Group LLC
13F
Company
0.07%
77,486
$1,654,000 30 Jun 2016
13F
NORTHERN TRUST CORP
13F
Company
0.06%
75,683
$1,615,000 30 Jun 2016
13F
STATE STREET CORP
13F
Company
0.06%
70,874
$1,513,000 30 Jun 2016
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
0.11%
123,159
$1,466,000 30 Jun 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.06%
67,346
$1,437,000 30 Jun 2016
13F
Emerald Acquisition Ltd.
13F
Company
0.05%
60,954
$1,302,000 30 Jun 2016
13F
JPMORGAN CHASE & CO
13F
Company
0.05%
60,925
$1,301,000 30 Jun 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.05%
57,913
$1,236,000 30 Jun 2016
13F
GLG LLC
13F
Company
0.03%
34,176
$730,000 30 Jun 2016
13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.02%
27,268
$582,000 30 Jun 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.02%
25,900
$553,000 30 Jun 2016
13F
Wildcat Capital Management, LLC
13F
Company
0.02%
25,000
$534,000 30 Jun 2016
13F
Spark Investment Management LLC
13F
Company
0.02%
23,290
$497,000 30 Jun 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.02%
22,754
$486,000 30 Jun 2016
13F
Bank of New York Mellon Corp
13F
Company
0.02%
21,626
$462,000 30 Jun 2016
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.02%
20,300
$433,000 30 Jun 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.02%
20,125
$430,000 30 Jun 2016
13F
Generale Societe
13F
Individual
0.01%
17,509
$374,000 30 Jun 2016
13F
SG Americas Securities, LLC
13F
Company
0.01%
17,509
$374,000 30 Jun 2016
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.01%
15,000
$320,000 30 Jun 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
14,643
$313,000 30 Jun 2016
13F
MARSHALL WACE, LLP
13F
Company
0.01%
11,408
$244,000 30 Jun 2016
13F
TEACHERS ADVISORS, LLC
13F
Company
0.01%
10,990
$235,000 30 Jun 2016
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.01%
10,443
$223,000 30 Jun 2016
13F
METROPOLITAN LIFE INSURANCE CO/NY
13F
Company
0.01%
8,886
$190,000 30 Jun 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
7,924
$168,000 30 Jun 2016
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
7,200
$154,000 30 Jun 2016
13F
NumerixS Investment Technologies Inc
13F
Company
0%
5,500
$117,000 30 Jun 2016
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0%
4,783
$102,000 30 Jun 2016
13F
GLG Partners LP
13F
Company
0%
4,697
$100,000 30 Jun 2016
13F
Nationwide Fund Advisors
13F
Company
0%
4,539
$97,000 30 Jun 2016
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0%
4,020
$85,827 30 Jun 2016
13F
Lombard Odier SCmA Compagnie
13F
Individual
0%
3,000
$64,000 30 Jun 2016
13F
BlackRock Finance, Inc.
13F
Company
0%
2,464
$53,000 30 Jun 2016
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
2,400
$51,000 30 Jun 2016
13F

Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q3 2016

As of 30 Sep 2016, Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,253,796 shares. The largest 10 holders included FMR LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, Temasek Holdings (Private) Ltd, Foresite Capital Management III, LLC, BlackRock Advisors LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, MORGAN STANLEY, and Artal Group S.A.. This page lists 64 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders
61
Q3 2016 holders
64
Holder diff
3
Investor Q2 2016 Shares Q3 2016 Shares Share Diff Share Chg % Q2 2016 Value $ Q3 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.